振德医疗
(603301)
| 流通市值：202.34亿 | | | 总市值：202.34亿 |
| 流通股本：2.64亿 | | | 总股本：2.64亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,224,060,634.54 | 1,000,414,155.6 | 4,329,600,957.47 | 3,184,260,011.92 |
| 营业总成本 | 2,067,911,454.1 | 946,996,184.26 | 4,007,579,350.63 | 2,957,601,989.7 |
| 其他经营收益 | | | | |
| 营业利润 | 175,366,402.97 | 67,205,679.64 | 328,345,126.21 | 249,723,836.87 |
| 利润总额 | 172,697,912.07 | 65,631,344.74 | 324,829,586.44 | 248,828,907.6 |
| 净利润 | 151,050,751.53 | 57,559,983.7 | 267,101,815.58 | 210,543,772.08 |
| 每股收益 | | | | |
| 其他综合收益 | -57,189,920.69 | -24,472,243.1 | -4,740,185.93 | 43,702,079.94 |
| 综合收益总额 | 93,860,830.84 | 33,087,740.6 | 262,361,629.65 | 254,245,852.02 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,904,636,195.42 | 2,822,449,443.51 | 2,859,048,307.2 | 2,918,094,914.5 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,436,907,829.57 | 5,542,341,984.91 | 5,541,839,465.46 | 5,486,517,555.15 |
| 资产总计 | 8,341,544,024.99 | 8,364,791,428.42 | 8,400,887,772.66 | 8,404,612,469.65 |
| 流动负债: | | | | |
| 流动负债合计 | 1,751,001,870.46 | 1,716,840,731.17 | 1,808,154,579.1 | 1,748,567,941.67 |
| 非流动负债: | | | | |
| 非流动负债合计 | 650,101,902.54 | 650,002,316.67 | 630,471,683 | 670,682,271 |
| 负债合计 | 2,401,103,773 | 2,366,843,047.84 | 2,438,626,262.1 | 2,419,250,212.67 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,676,320,067.27 | 5,724,963,640.48 | 5,686,734,447.2 | 5,702,974,414.34 |
| 股东权益合计 | 5,940,440,251.99 | 5,997,948,380.58 | 5,962,261,510.56 | 5,985,362,256.98 |
| 负债和股东权益合计 | 8,341,544,024.99 | 8,364,791,428.42 | 8,400,887,772.66 | 8,404,612,469.65 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,485,077,810.16 | 1,335,158,440.9 | 4,783,425,734.77 | 3,695,211,630.06 |
| 经营活动现金流出小计 | 2,440,180,254.73 | 1,329,405,144.37 | 4,244,937,005.39 | 3,432,572,428.74 |
| 经营活动产生的现金流量净额 | 44,897,555.43 | 5,753,296.53 | 538,488,729.38 | 262,639,201.32 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 373,764,026.86 | 141,040,558.52 | 710,674,017.46 | 527,019,627.25 |
| 投资活动现金流出小计 | 397,784,523.71 | 294,283,738.77 | 1,508,309,772.18 | 1,132,986,481.25 |
| 投资活动产生的现金流量净额 | -24,020,496.85 | -153,243,180.25 | -797,635,754.72 | -605,966,854 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 888,750,325 | 107,673,393.32 | 1,637,202,554.25 | 1,536,500,000 |
| 筹资活动现金流出小计 | 1,023,086,601.27 | 115,830,937.43 | 1,192,858,072.94 | 916,812,763.66 |
| 筹资活动产生的现金流量净额 | -134,336,276.27 | -8,157,544.11 | 444,344,481.31 | 619,687,236.34 |
| 汇率变动对现金及现金等价物的影响 | -18,241,185.56 | -10,686,175.56 | -13,540,887.78 | -354,792.69 |
| 现金及现金等价物净增加额 | -131,700,403.25 | -166,333,603.39 | 171,656,568.19 | 276,004,790.97 |
| 期末现金及现金等价物余额 | 629,289,279.94 | 594,656,079.8 | 760,989,683.19 | 865,337,905.97 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -131,700,403.25 | - | 171,656,568.19 | - |